Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with (“pseudo-randomized”) treatment allocation by the health insurance provider

INTRODUCTION: Despite a large number of trials, the role of bevacizumab (BEV) in the treatment of recurrent high-grade gliomas is still controversial. Evidence regarding an effect on overall survival in this context is ultimately inconclusive. At the Department of Radiation Oncology at Erlangen, Ger...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Neurooncol
Hauptverfasser: Hofmann, Susanne, Schmidt, Manuel Alexander, Weissmann, Thomas, Eyüpoglu, Ilker, Strnad, Annedore, Semrau, Sabine, Fietkau, Rainer, Putz, Florian, Lettmaier, Sebastian
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer US 2020
Schlagworte:
Clinical Study
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316675/
https://ncbi.nlm.nih.gov/pubmed/32409944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-020-03533-5
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge